Litigation Details for Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc. (D. Del. 2014)
✉ Email this page to a colleague
Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc. (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-07-01 |
| Court | District Court, D. Delaware | Date Terminated | 2018-03-14 |
| Cause | 15:1126 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Both | Referred To | |
| Parties | UNIVERSITA DEGLI STUDI DI CAGLIARI | ||
| Patents | 7,964,580; 8,637,475 | ||
| Attorneys | Anthony M. Zupcic | ||
| Firms | Fish & Richardson P.C. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc.
Details for Idenix Pharmaceuticals LLC v. Gilead Sciences, Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-05-20 | 117 | Exhibit A | pat – 91:42-53 (now US 8,637,475): ’600 pat – 91… The ’054 patent claims (Exh. B), including: ’054 Patent Specification (Exh. B):… The ’054 patent claims (Exh. B), including: ’054 Patent Specification (Exh. B)… The ’597 patent claims (Exh. C), including: ’597 Patent Specification (Exh. C)…pyrimidine nucleoside.” The ’597 patent is a continuation of the ’054 patent and shares an identical specification | External link to document |
| 2017-02-23 | 536 | Sofia) (testimony re DX-2721, U.S. Pat. No. 7,964,580). …portfolio of patents, not just a single patent. The Pharmasset-Roche agreement licensed every patent Pharmasset…Merck-Roche] agreement, it is for a patent, this agreement is for a patent related to Hepatitis C… an “entire patent portfolio” was “vastly different” from a license to “only one patent.”); Trell v.…licensed patents. PX-1606.11 Having failed to discuss or even identify the licensed patents, Mr. Carter | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
